Product

Company

Clareo Health | Efficacy of GONB in Patients of Migraine

NCT05679765·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pain Medicine Department

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

Patients with known allergies to local anaesthetics
pregnancy
history of cranial or cervical surgery
head injury
headaches secondary to medication overuse
patients with uncontrolled systemic disease like blood pressure, diabetes mellitus
hypo or hyperthyroidism
patient who had already received GONB or botulinum toxin type A therapy within last 6 months
major psychiatric disorder
history of chronic pain syndromes

The record

StatusCompleted

PhasePhase 4

Taking part50

StartedApr 2022

UpdatedJan 12, 2023

Conditions

Where1